Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Clasificación en acciones #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Precio por acción
$0.01292666
Última sincronización: 2025-04-08
Capitalización bursátil
$157.54K
Cambio (1 día)
6.84%
Cambio (1 año)
0.00%
País
GB
Comercio Synairgen plc (SNG)

Categoría

EPS de Synairgen plc (SNG)
EPS a fecha de June 2024 TTM: $-0.04
Según los últimos informes financieros y el precio de las acciones de Synairgen plc, el EPS actual de la empresa (TTM) es $-0.04. Al final del año 2022, la empresa tenía un EPS de $-0.11 una disminución en comparación con al EPS de 2021, que fue de $-0.32.
Historial de EPS de Synairgen plc desde 2004 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-0.04 -13.00%
2023 $-0.05 -49.81%
2022 $-0.11 -67.33%
2021 $-0.32 150.97%
2020 $-0.13 176.28%
2019 $-0.05 5.88%
2018 $-0.04 -274.70%
2017 $0.03 -166.75%
2016 $-0.04 4.12%
2015 $-0.04 -273.33%
2014 $0.02 -146.98%
2013 $-0.04 -11.13%
2012 $-0.05 -41.31%
2011 $-0.09 34.96%
2010 $-0.06 -65.03%
2009 $-0.18 -7.49%
2008 $-0.20 44.55%
2007 $-0.14 67.04%
2006 $-0.08 39.93%
2005 $-0.06 112.04%
2004 $-0.03 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -39,916.09%
US
$27.74 -63,870.11%
NL
- -
CH
- -
KR
$13.70 -31,594.48%
BE